Literature DB >> 18362112

Intraretinal leakage and oxidation of LDL in diabetic retinopathy.

Mingyuan Wu1, Ying Chen, Kenneth Wilson, Alin Chirindel, Michael A Ihnat, Yongxin Yu, Michael E Boulton, Luke I Szweda, Jian-Xing Ma, Timothy J Lyons.   

Abstract

PURPOSE: The pathogenesis of diabetic retinopathy (DR) is not fully understood. Clinical studies suggest that dyslipidemia is associated with the initiation and progression of DR. However, no direct evidence supports this theory.
METHODS: Immunostaining of apolipoprotein B100 (ApoB100, a marker of low-density lipoprotein [LDL]), macrophages, and oxidized LDL was performed in retinal sections from four different groups of subjects: nondiabetic, type 2 diabetic without clinical retinopathy, diabetic with moderate nonproliferative diabetic retinopathy (NPDR), and diabetic with proliferative diabetic retinopathy (PDR). Apoptosis was characterized using the TUNEL assay. In addition, in cell culture studies using in vitro-modified LDL, the induction of apoptosis by heavily oxidized-glycated LDL (HOG-LDL) in human retinal capillary pericytes (HRCPs) was assessed.
RESULTS: Intraretinal immunofluorescence of ApoB100 increased with the severity of DR. Macrophages were prominent only in sections from diabetic patients with PDR. Merged images revealed that ApoB100 partially colocalized with macrophages. Intraretinal oxidized LDL was absent in nondiabetic subjects but present in all three diabetic groups, increasing with the severity of DR. TUNEL-positive cells were present in retinas from diabetic subjects but absent in those from nondiabetic subjects. In cell culture, HOG-LDL induced the activation of caspase, mitochondrial dysfunction, and apoptosis in HRCPs.
CONCLUSIONS: These findings suggest a potentially important role for extravasated, modified LDL in promoting DR by promoting apoptotic pericyte loss.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18362112     DOI: 10.1167/iovs.07-1440

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  45 in total

1.  Reduction of experimental diabetic vascular leakage and pericyte apoptosis in mice by delivery of αA-crystallin with a recombinant adenovirus.

Authors:  Y H Kim; S Y Park; J Park; Y S Kim; E M Hwang; J Y Park; G S Roh; H J Kim; S S Kang; G J Cho; W S Choi
Journal:  Diabetologia       Date:  2012-07-08       Impact factor: 10.122

2.  Tyrosine nitration of prostacyclin synthase is associated with enhanced retinal cell apoptosis in diabetes.

Authors:  Ming-Hui Zou; Hongliang Li; Chaoyong He; Mingkai Lin; Timothy J Lyons; Zhonglin Xie
Journal:  Am J Pathol       Date:  2011-10-18       Impact factor: 4.307

Review 3.  Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers.

Authors:  Timothy J Lyons; Arpita Basu
Journal:  Transl Res       Date:  2012-01-31       Impact factor: 7.012

4.  Mechanisms of modified LDL-induced pericyte loss and retinal injury in diabetic retinopathy.

Authors:  D Fu; M Wu; J Zhang; M Du; S Yang; S M Hammad; K Wilson; J Chen; T J Lyons
Journal:  Diabetologia       Date:  2012-08-31       Impact factor: 10.122

Review 5.  Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms.

Authors:  Alin Stirban; Thomas Gawlowski; Michael Roden
Journal:  Mol Metab       Date:  2013-12-07       Impact factor: 7.422

6.  Immune complex formation in human diabetic retina enhances toxicity of oxidized LDL towards retinal capillary pericytes.

Authors:  Dongxu Fu; Jeremy Y Yu; Mingyuan Wu; Mei Du; Ying Chen; Souzan A Abdelsamie; Yanchun Li; Junping Chen; Michael E Boulton; Jian-Xing Ma; Maria F Lopes-Virella; Gabriel Virella; Timothy J Lyons
Journal:  J Lipid Res       Date:  2014-03-10       Impact factor: 5.922

Review 7.  The role of dyslipidemia in diabetic retinopathy.

Authors:  Sandra S Hammer; Julia V Busik
Journal:  Vision Res       Date:  2017-05-26       Impact factor: 1.886

Review 8.  Whole exome sequencing identification of novel candidate genes in patients with proliferative diabetic retinopathy.

Authors:  Cindy Ung; Angie V Sanchez; Lishuang Shen; Samaneh Davoudi; Tina Ahmadi; Daniel Navarro-Gomez; Ching J Chen; Heather Hancock; Alan Penman; Suzanne Hoadley; Mark Consugar; Carlos Restrepo; Vinay A Shah; Joseph F Arboleda-Velasquez; Lucia Sobrin; Xiaowu Gai; Leo A Kim
Journal:  Vision Res       Date:  2017-05-09       Impact factor: 1.886

9.  Pigment epithelium-derived factor mitigates inflammation and oxidative stress in retinal pericytes exposed to oxidized low-density lipoprotein.

Authors:  Sarah X Zhang; Joshua J Wang; Azar Dashti; Kenneth Wilson; Ming-Hui Zou; Luke Szweda; Jian-Xing Ma; Timothy J Lyons
Journal:  J Mol Endocrinol       Date:  2008-06-27       Impact factor: 5.098

Review 10.  Biomarkers in Diabetic Retinopathy.

Authors:  Alicia J Jenkins; Mugdha V Joglekar; Anandwardhan A Hardikar; Anthony C Keech; David N O'Neal; Andrzej S Januszewski
Journal:  Rev Diabet Stud       Date:  2015-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.